Deltagen, Inc. engages in the provision of drug discovery tools and services to the biopharmaceutical industry. The company is headquartered in San Carlos, California. The company went IPO on 2000-08-03. The firm offers a suite of programs designed to manage the efficiency of drug discovery, including access to biological models, as well as both small-molecule and secreted protein drug targets. In addition, it offers target validation data in the areas of immunology and metabolic diseases. The firm's biology approach is designed to help clear the first and major hurdle of drug target discovery: lead validation. Its DeltaBase is a searchable database of in vivo-derived mammalian gene function information and gene targets. DeltaOne from the Company provides per-gene access to the knockout mice and/or phenotypic data needed.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2015
12/31/2014
12/31/2013
12/31/2012
12/31/2011
Revenue
0
0
0
1
1
0
Revenue Growth (YoY)
-100%
--
-100%
0%
--
-100%
Cost of Revenue
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
Selling, General & Admin
--
--
--
--
--
--
Research & Development
--
--
--
--
--
--
Operating Expenses
0
0
0
0
0
3
Other Non Operating Income (Expenses)
--
--
--
--
--
--
Pretax Income
0
0
0
-4
-1
-2
Income Tax Expense
0
0
0
0
0
0
Net Income
0
0
0
-4
-1
-2
Net Income Growth
-100%
--
-100%
300%
-50%
--
Shares Outstanding (Diluted)
38.85
38.85
38.85
38.85
38.85
38.85
Shares Change (YoY)
0%
0%
0%
0%
0%
0%
EPS (Diluted)
0
0
0
-0.11
-0.03
-0.07
EPS Growth
-104%
-130%
-104%
279%
-59%
316%
Free Cash Flow
0
0
0
0
1
-3
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
0%
0%
0%
0%
0%
0%
Operating Margin
0%
0%
0%
0%
0%
0%
Profit Margin
0%
0%
0%
-400%
-100%
0%
Free Cash Flow Margin
0%
0%
0%
0%
100%
0%
EBITDA
0
0
0
0
0
-2
EBITDA Margin
0%
0%
0%
0%
0%
0%
D&A For EBITDA
0
0
0
0
0
0
EBIT
0
0
0
0
0
-2
EBIT Margin
0%
0%
0%
0%
0%
0%
Effective Tax Rate
0%
0%
0%
0%
0%
0%
Follow-Up Questions
What are Deltagen Inc's key financial statements?
According to the latest financial statement (Form-10K), Deltagen Inc has a total asset of $1, Net loss of $0
What are the key financial ratios for DGEN?
Deltagen Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.
How is Deltagen Inc's revenue broken down by segment or geography?
Deltagen Inc largest revenue segment is Accommodation and Other, at a revenue of 421,537,000 in the most earnings release.For geography, Australia is the primary market for Deltagen Inc, at a revenue of 426,956,000.
Is Deltagen Inc profitable?
no, according to the latest financial statements, Deltagen Inc has a net loss of $0
Does Deltagen Inc have any liabilities?
no, Deltagen Inc has liability of 0
How many outstanding shares for Deltagen Inc?
Deltagen Inc has a total outstanding shares of 38.85